标题
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
作者
关键词
-
出版物
Biomed Research International
Volume 2017, Issue -, Pages 1-10
出版商
Hindawi Limited
发表日期
2017-08-16
DOI
10.1155/2017/1253425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip
- (2017) Michaela Luconi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro
- (2016) Xian-wei Wang et al. ACTA PHARMACOLOGICA SINICA
- Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
- (2016) Rury R. Holman et al. AMERICAN HEART JOURNAL
- Sitagliptin decreases ventricular arrhythmias by attenuated glucose-dependent insulinotropic polypeptide (GIP)-dependent resistin signalling in infarcted rats
- (2016) T.-M. Lee et al. BIOSCIENCE REPORTS
- Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications
- (2016) Philippe Gabriel Steg et al. CIRCULATION
- Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
- (2016) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
- (2016) Simon A. Hawley et al. DIABETES
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin-1 (CAV-1) pathway
- (2016) Valentina Vellecco et al. DIABETES OBESITY & METABOLISM
- SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
- (2016) Naveed Sattar et al. DIABETOLOGIA
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials
- (2016) J. Kongwatcharapong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
- (2016) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease
- (2016) Shingo Kato et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase
- (2016) SONG-TAO TANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase
- (2016) Anna Solini et al. VASCULAR PHARMACOLOGY
- Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic‐Banded Mini‐Swine
- (2016) Jessica A. Hiemstra et al. Journal of the American Heart Association
- Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart
- (2015) Amanda P. Waller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”
- (2015) Benjamin M. Scirica et al. CIRCULATION
- Dipeptidyl Peptidase-4 Inhibition Attenuates Arrhythmias via a Protein Kinase A-Dependent Pathway in Infarcted Hearts
- (2015) Tsung-Ming Lee et al. CIRCULATION JOURNAL
- DPP4 in Cardiometabolic Disease: Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition
- (2015) J. Zhong et al. CIRCULATION RESEARCH
- Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 AxisCLINICAL PERSPECTIVE
- (2015) Morihiko Aoyama et al. Circulation-Heart Failure
- Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium
- (2015) Markus Wallner et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats
- (2015) Md. Ashraful Alam et al. Diabetology & Metabolic Syndrome
- Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α
- (2015) Kim A. Connelly et al. Journal of Diabetes
- Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
- (2015) Wellington Santana da Silva Júnior et al. Biomed Research International
- Dipeptidyl-Peptidase-4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low-Density Lipoprotein (LDL) Receptor-Deficient Mice
- (2015) K. Akita et al. Journal of the American Heart Association
- Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
- (2014) Mitchel Tate et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
- (2014) Toru Miyoshi et al. Cardiovascular Diabetology
- Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4
- (2014) N. Hamdani et al. CARDIOVASCULAR RESEARCH
- Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism
- (2014) Masakazu Ishii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Saxagliptin Restores Vascular Mitochondrial Exercise Response in the Goto-Kakizaki Rat
- (2014) Amy C. Keller et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
- (2014) Rury R Holman et al. LANCET
- The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Na-Hyung Kim et al. Biomed Research International
- Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats
- (2013) Nattayaporn Apaijai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials
- (2013) Pitchai Balakumar et al. CELLULAR SIGNALLING
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart
- (2013) Kroekkiat Chinda et al. Diabetes & Vascular Disease Research
- Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats
- (2013) Annayya R. Aroor et al. ENDOCRINOLOGY
- The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes
- (2013) T-I Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
- (2013) Paulus Wohlfart et al. Journal of Translational Medicine
- GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
- (2013) Minsuk Kim et al. NATURE MEDICINE
- DPP-4 Inhibition Attenuates Cardiac Dysfunction and Adverse Remodeling Following Myocardial Infarction in Rats with Experimental Diabetes
- (2012) Kim Alexander Connelly et al. Cardiovascular Therapeutics
- Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats
- (2012) R. Preston Mason et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac Function
- (2011) Douglas G. Tilley CIRCULATION RESEARCH
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
- (2011) Jacob Lønborg et al. EUROPEAN HEART JOURNAL
- Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice
- (2011) M. Angelyn Bethel et al. Current Cardiology Reports
- Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
- (2010) Douglas G. Tilley et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
- (2010) J. Koska et al. DIABETES CARE
- Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
- (2010) C. Lamanna et al. DIABETES OBESITY & METABOLISM
- Functional effects of glucose transporters in human ventricular myocardium
- (2010) Dirk von Lewinski et al. EUROPEAN JOURNAL OF HEART FAILURE
- β-Arrestin–dependent activation of Ca2+/calmodulin kinase II after β1–adrenergic receptor stimulation
- (2010) Supachoke Mangmool et al. JOURNAL OF CELL BIOLOGY
- Role of myocardial viscoelasticity in disturbances of electrical and mechanical activity in calcium overloaded cardiomyocytes: Mathematical modeling
- (2010) Leonid B. Katsnelson et al. JOURNAL OF THEORETICAL BIOLOGY
- Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
- (2010) Dirk von Lewinski et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
- The cAMP binding protein Epac regulates cardiac myofilament function
- (2009) O. Cazorla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention of Heart Failure
- (2008) Douglas D. Schocken et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started